X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER BIOLOGY & THERAPY

期刊標題檢索 CANCER BIOL THE 最新評論: May I ask if withdrawing a submission requires writing directly to the... (2022-06-10)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER BIOLOGY & THERAPY]您好,您是該頁面的第 74829 位訪客。

期刊簡介
期刊名稱CANCER BIOLOGY & THERAPY CANCER BIOLOGY & THERAPY
LetPub Score
6.4
51 ratings
Rate

Reputation
7.5

Influence
5.3

Speed
6.9

期刊簡稱CANCER BIOL THER
ISSN1538-4047
E-ISSN1555-8576
h-index101
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.000.9140.688
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q194 / 404
Category: Medicine
Subcategory: Pharmacology
Q290 / 313
Category: Medicine
Subcategory: Cancer Research
Q282 / 230
Category: Medicine
Subcategory: Molecular Medicine
Q265 / 178

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
官方網站http://www.tandfonline.com/loi/kcbt20#.V4he8kz9cSQ
在線稿件提交https://www.editorialmanager.com/CBT
開放訪問No
出版商Landes Bioscience
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2002
每年文章數81每年文章數趨勢
黃金OA百分比79.27%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ286/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4047%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2.3 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【CANCER BIOLOGY & THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS331002
    CANCER RESEARCH312134
    BMC CANCER245507
    Asian Pacific Journal of Cancer Prevention219229
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191631
    CLINICAL CANCER RESEARCH181667
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176425
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
  •  

    CANCER BIOLOGY & THERAPY CANCER BIOLOGY & THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CANCER BIOLOGY & THERAPY] 的評論撰寫評論
作者: jinglepph


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-10 22:36:03 評論於
May I ask if withdrawing a submission requires writing directly to the editor or withdrawing it through the system? Do I need to wait for a response from the editorial department before resubmitting?
(0) 讚! | jinglepph

作者: DreamCar


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-30 12:37:29 評論於
A very trashy magazine, took 6 months for the first review, and had to keep urging for minor revisions. After the revisions, there was no news for 14 months. They didn't reply to emails, so I withdrew the submission without waiting any longer. It was too much of a delay. I suggest that students should not submit to this magazine, it's a huge disappointment!!!
(0) 讚! | DreamCar

作者: 木子


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2020-08-10 19:09:33 評論於
After waiting for five months, it was directly rejected, without being sent for external review. I hope it can still be processed as soon as possible in the future.

(0) 讚! | 木子

作者: 木木


領域: 医学
審稿時間: 8.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-24 08:52:42 評論於
It was with editor for 4 months before being sent for review. It has been reviewed for 4 months, but there is no news. Be careful to submit if you are anxious to graduate. the editorial office is estimated to be fighting the pandemic recently, and it is no longer 2 or 3 months as said.

(5) 讚! | 木木

作者: 被逼无奈搞科研


領域: 医学
審稿時間: 6.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-17 17:01:43 評論於
There is no news received for more than a month, after being received by journal. It is so disappointing.

(0) 讚! | 被逼无奈搞科研

作者: Parry


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2019-01-18 17:53:05 評論於
Although this is not a top journal in the field, I am very excited about my recent submission. Have people had good experiences with publishing in this journal?

(2) 讚! | Parry

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CANCER BIOLOGY & THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*